{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:11:45Z","timestamp":1790039505876,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jpba.2013.02.031","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T18:25:49Z","timestamp":1362075949000},"page":"122-128","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-Desisobutyl-11-benzylsibutramine"],"prefix":"10.1016","volume":"83","author":[{"given":"Daniel J.","family":"Mans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Gucinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Gryniewicz-Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Mecker-Pogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff L.-F.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.02.031_bib0005","unstructured":"http:\/\/www.cdc.gov\/obesity\/data\/facts.html, Overweight and obesity."},{"key":"10.1016\/j.jpba.2013.02.031_bib0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.111.023499","article-title":"What cost weight loss?","volume":"125","author":"Hiatt","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jpba.2013.02.031_bib0015","unstructured":"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm312468.htm, FDA approves weight-management drug Qsymia."},{"key":"10.1016\/j.jpba.2013.02.031_bib0020","article-title":"N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate for use in treating depression","volume":"2184122A","author":"Jeffery","year":"1987","journal-title":"Brit. UK Pat. Appl. GB"},{"key":"10.1016\/j.jpba.2013.02.031_bib0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/j.1550-8528.1995.tb00227.x","article-title":"Sibutramine: a novel new agent for obesity treatment","volume":"3","author":"Ryan","year":"1995","journal-title":"Obes. Res."},{"key":"10.1016\/j.jpba.2013.02.031_bib0030","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1039\/p19960002583","article-title":"Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites","volume":"1","author":"Jeffery","year":"1996","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.jpba.2013.02.031_bib0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","article-title":"The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation","volume":"12","author":"Buckett","year":"1988","journal-title":"Prog. Neuro-Psychoph."},{"key":"10.1016\/j.jpba.2013.02.031_bib0040","unstructured":"http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/EndocrinologicandMetabolicDrugsAdvisoryCommittee\/UCM225573.pdf, Meridia\u00ae (sibutramine hydrochloride monohydrate) Sponsor Briefing Document \u2013 EMDAC Meeting 13 August 2010."},{"key":"10.1016\/j.jpba.2013.02.031_bib0045","unstructured":"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm228812.htm, Abbott Laboratories agrees to withdraw its obesity drug Meridia."},{"key":"10.1016\/j.jpba.2013.02.031_bib0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpba.2010.09.017","article-title":"Using a portable ion mobility spectrometer to screen dietary supplements for sibutramine","volume":"54","author":"Dunn","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.02.031_bib0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpba.2012.07.020","article-title":"Qualitative screening for adulterants in weight-loss supplements by ion mobility spectrometry","volume":"71","author":"Dunn","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.02.031_bib0060","first-page":"20","article-title":"Isolation and identification of a sibutramine analogue in a healthy food for weight loss","volume":"15","author":"Lai","year":"2007","journal-title":"Y. Ship. Fen."},{"key":"10.1016\/j.jpba.2013.02.031_bib0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1255\/ejms.797","article-title":"Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography\u2013tandem mass spectrometry","volume":"12","author":"Thevis","year":"2006","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2013.02.031_bib0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/ac1028598","article-title":"Rapid limit tests for metal impurities in pharmaceutical materials by X-ray fluorescence spectroscopy using wavelet transform filtering","volume":"83","author":"Arzhantsev","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2013.02.031_bib0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jpba.2008.12.002","article-title":"Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry","volume":"49","author":"Gryniewicz","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.02.031_bib0080","first-page":"24","article-title":"Spectroscopic methods for rapid determination of diethylene glycol in glycerin","volume":"10","author":"Gryniewicz","year":"2007","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.jpba.2013.02.031_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1366\/10-05976","article-title":"Multivariate calibration and instrument standardization for the rapid detection of diethylene glycol in glycerin by Raman spectroscopy","volume":"65","author":"Gryniewicz-Ruzicka","year":"2011","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.jpba.2013.02.031_bib0090","first-page":"58","article-title":"Pharmaceutical surveillance with rapid spectroscopic screening technologies","volume":"13","author":"Kauffman","year":"2010","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.jpba.2013.02.031_bib0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jpba.2010.11.042","article-title":"Detection of diethylene glycol adulteration in propylene glycol \u2013 method validation through a multi-instrument collaborative study","volume":"54","author":"Li","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.02.031_bib0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpba.2012.11.031","article-title":"Rapid-screening detection of acetildenafils, sildenafils and avanafil by ion mobility spectrometry","volume":"75","author":"Mans","year":"2013","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T06:25:44Z","timestamp":1539843944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":20,"alternative-id":["S0731708513000915"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.02.031","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}